Clinical features associated with costs in early AD: baseline data from the Predictors Study

Area of Science:

• Gerontology
• Neuroscience
• Health Economics

Background:

• Limited studies explore Alzheimer disease (AD) costs across multiple dimensions.
• Few studies correlate detailed clinical characteristics with AD patient costs.

Purpose of the Study:

• To empirically estimate the incremental effects of patient clinical characteristics on disease costs.
• To analyze the relationship between specific AD clinical features and direct medical, nonmedical, and indirect care costs.

Main Methods:

• Utilized baseline data from 180 patients in the Predictors Study cohort with probable AD.
• Assessed clinical characteristics including cognitive status, functional capacity, and behavioral symptoms.
• Quantified direct medical, direct nonmedical, and indirect (caregiving time) costs.

Main Results:

• A 1-point increase in the Blessed Dementia Rating Scale score correlated with $1,411 in direct medical costs and $2,718 in unpaid caregiving costs.
• Direct medical costs were $3,777 higher for patients with depressive symptoms compared to those without.
• Poorer functional status demonstrated a significant association with increased medical and unpaid caregiving costs.

Conclusions:

• Medical care and unpaid caregiving costs are differentially influenced by patient clinical characteristics in Alzheimer disease.
• Interventions targeting activities of daily living may be particularly effective in reducing overall disease burden.
• Understanding these cost drivers is crucial for developing effective support strategies for AD patients and caregivers.